Abstract
Although significant progress has been made towards the understanding of cellular and molecular mechanisms underlying the pathogenetic pathways of transplant arteriosclerosis, its knowledge is still not comprehensive. Nevertheless, experimental and clinical studies have enabled us to discover some of the complex processes involved in the progression and evolution of transplant arteriosclerosis. Despite the advances in transplantation immunology and atherosclerosis research, transplant arteriosclerosis still remains a major cause of allograft failure. A curative treatment, in order to inhibit or at least modify the development of transplant arteriosclerosis, is urgently needed. This review article highlights some of the more recent aspects of cellular and molecular pathology of transplant arteriosclerosis that may add to our current and future diagnostic and curative interventions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
